Why add Optimist Screening to safety protocols?
Optimist Screening is commercially available to help identify one of the early symptoms associated with the virus– loss of smell. Many recent studies world wide indicate that loss of smell (Anosmia) is associated with an 80%+ likelihood of progressing to positive test results. Screening for loss of smell works particularly well as an add-on to temperature checks as patients are 27 times more likely to experience smell loss but are only around 2.2 to 2.6 times more likely to have fever, cough or respiratory difficulty, when compared to patients without COVID-19. (2,3,4,5,6,7,8)